Stay updated on Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.

Latest updates to the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedGastric cancer was added to the list of conditions. The study protocol version was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check27 days agoChange DetectedUI and metadata updates include showing the glossary, adding a 'Last Update Submitted that Met QC Criteria' timestamp, a 'No FEAR Act Data' notice, and a 'Revision: v3.4.0' label, replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4. Removed Revision: v3.3.3 from the page's revision notes.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section with a Texas site and updated the page to Revision: v3.3.3; removed the HHS Vulnerability Disclosure and the Texas Locations entry from the previous version.SummaryDifference0.2%

- Check92 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. No substantive changes to the study details or related information.SummaryDifference0.0%

Stay in the know with updates to Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.